Latest Period
Q2 2026
Security Snapshot
Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY) Institutional Ownership
CUSIP: 75943R102
13F Institutional Holders and Ownership History from Q3 2020 to Q2 2026
Institutions Reporting
256
Shares (Excl. Options)
246,546,186
Price
$18.71
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- RLAY on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 246,546,186
- Total 13F value
- $4,577,983,154
- Portfolio coverage rank
- 0.01%
- Share change
- +62,698,781
- Value change
- +$1,171,111,045
- Number of holders
- 256
- Shares outstanding
- 218,181,818
- SEC-reported price per share
- $19.27
- Insider filing price
- $19.27
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 75943R102.
- 256 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 242 to 256 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,831,798,542 to $4,577,983,154.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 256 institutions filings for Q2 2026.
Security key
75943R102
Latest holder period
Q2 2026
13F holders
256
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
RLAY full holder history
Relay Therapeutics, Inc. SEC filings
Relay Therapeutics, Inc. company facts
Relay Therapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 75943R102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
RLAY
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10% | +6.7% | $398,401,171 | +$23,518,100 | 21,270,751 | +6.3% | FMR LLC | 31 Jul 2026 |
| PERCEPTIVE ADVISORS LLC | 6.4% | -36% | $264,208,883 | +$255,996,321 | 14,106,187 | +3117% | Perceptive Advisors LLC | 30 Jun 2026 |
| Casdin Capital, LLC | 7.5% | $110,010,236 | 13,003,574 | CASDIN CAPITAL, LLC | 31 Dec 2025 | |||
| Commodore Capital LP | 5.5% | -44% | $224,760,000 | -$93,650,000 | 12,000,000 | -29% | Commodore Capital LP | 30 Jun 2026 |
| BlackRock, Inc. | 6.1% | -30% | $32,882,558 | -$13,928,338 | 10,308,012 | -30% | BlackRock, Inc. | 31 Mar 2025 |
As of 30 Jun 2026, 256 institutional investors reported holding 246,546,186 shares of Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY). This represents 113% of the company’s total 218,181,818 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
88%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 13% | 27,904,963 | 0% | 6.8% | $522,101,858 |
| FMR LLC | 9.2% | 20,110,113 | +444% | 0.02% | $376,260,219 |
| Casdin Capital, LLC | 7.3% | 16,035,240 | +11% | 15% | $300,019,340 |
| BlackRock, Inc. | 7% | 15,288,202 | +18% | 0% | $286,042,260 |
| PERCEPTIVE ADVISORS LLC | 6.5% | 14,106,187 | +45% | 4.1% | $263,926,759 |
| Commodore Capital LP | 5.5% | 12,000,000 | -29% | 13% | $224,520,000 |
| STATE STREET CORP | 4.6% | 10,125,381 | +62% | 0.01% | $189,474,192 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.1% | 8,964,423 | +21% | 0% | $167,724,354 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.5% | 7,708,507 | +300% | 0.01% | $144,227,000 |
| Nextech Invest Ltd. | 3.1% | 6,776,506 | +23% | 6.1% | $126,788,427 |
| Bellevue Group AG | 2.8% | 6,185,970 | -21% | 2.4% | $115,739,499 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 4,726,576 | +35% | 0% | $88,448,664 |
| TCG Crossover Management, LLC | 2% | 4,273,356 | 0% | 1.9% | $79,954,491 |
| ALLIANCEBERNSTEIN L.P. | 1.9% | 4,095,600 | +2720% | 0.01% | $40,751,220 |
| MORGAN STANLEY | 1.8% | 3,851,071 | +169% | 0% | $72,053,540 |
| Siren, L.L.C. | 1.7% | 3,650,000 | 1.4% | $68,291,500 | |
| GOLDMAN SACHS GROUP INC | 1.6% | 3,408,701 | +34% | 0.01% | $63,776,796 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.5% | 3,343,496 | 0.2% | $62,556,810 | |
| Kynam Capital Management, LP | 1.5% | 3,300,000 | +132% | 3.4% | $61,743,000 |
| DIMENSIONAL FUND ADVISORS LP | 1.4% | 3,127,564 | +6.4% | 0.01% | $58,533,626 |
| Spruce Street Capital LP | 1.4% | 2,984,125 | 0% | 11% | $55,832,979 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3% | 2,892,785 | +55% | 0% | $54,124,007 |
| BAKER BROS. ADVISORS LP | 1.3% | 2,826,783 | +144% | 0.27% | $52,889,110 |
| BANK OF AMERICA CORP /DE/ | 1.2% | 2,695,108 | +39% | 0% | $50,425,471 |
| MPM BIOIMPACT LLC | 1.1% | 2,415,672 | +2.4% | 2.8% | $45,197,223 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
24
Latest
Q2 2026
Rows shown
1-24 of 24
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 246,546,186 | $4,577,983,154 | +$1,171,111,045 | $18.71 | 256 |
| 2026 Q1 | 184,153,444 | $1,831,798,542 | +$121,908,346 | $9.95 | 242 |
| 2025 Q4 | 173,567,140 | $1,468,277,175 | +$55,238,266 | $8.46 | 226 |
| 2025 Q3 | 166,100,415 | $866,877,590 | -$18,449,389 | $5.22 | 195 |
| 2025 Q2 | 170,927,354 | $591,366,333 | +$36,190,035 | $3.46 | 203 |
| 2025 Q1 | 162,665,545 | $426,190,863 | -$16,276,230 | $2.62 | 205 |
| 2024 Q4 | 163,889,986 | $675,297,060 | -$42,360,167 | $4.12 | 197 |
| 2024 Q3 | 163,415,012 | $1,156,675,796 | +$253,277,512 | $7.08 | 193 |
| 2024 Q2 | 126,697,163 | $826,050,230 | -$42,426,305 | $6.52 | 171 |
| 2024 Q1 | 132,236,260 | $1,097,561,545 | +$24,572,655 | $8.30 | 182 |
| 2023 Q4 | 127,244,702 | $1,400,985,578 | -$17,110,979 | $11.01 | 176 |
| 2023 Q3 | 130,456,510 | $1,097,122,997 | -$2,918,566 | $8.41 | 169 |
| 2023 Q2 | 129,294,786 | $1,623,964,520 | -$20,848,790 | $12.56 | 159 |
| 2023 Q1 | 131,039,866 | $2,156,444,291 | +$53,163,179 | $16.47 | 155 |
| 2022 Q4 | 128,192,171 | $1,915,159,649 | +$58,936,160 | $14.94 | 163 |
| 2022 Q3 | 123,551,085 | $2,763,964,560 | +$25,518,843 | $22.37 | 153 |
| 2022 Q2 | 120,596,011 | $2,019,993,086 | +$124,571,798 | $16.75 | 137 |
| 2022 Q1 | 113,095,261 | $3,384,210,971 | +$67,735,824 | $29.93 | 133 |
| 2021 Q4 | 110,982,949 | $3,407,692,692 | +$588,792,014 | $30.71 | 128 |
| 2021 Q3 | 91,778,622 | $2,894,965,132 | +$74,331,777 | $31.53 | 132 |
| 2021 Q2 | 89,144,608 | $3,261,742,353 | +$138,052,473 | $36.59 | 124 |
| 2021 Q1 | 85,493,244 | $2,955,555,198 | -$171,240,328 | $34.57 | 135 |
| 2020 Q4 | 87,701,562 | $3,644,892,889 | +$108,159,345 | $41.56 | 115 |
| 2020 Q3 | 84,683,348 | $3,603,495,710 | +$3,603,495,710 | $42.59 | 94 |